SCL at a glance
STEPAN CO (SCL, SEC CIK 94049) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on October 28, 2026 and Form 4 insider filings as recently as November 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), STEPAN CO (SCL) reported revenue of $2.3 billion (up 7.0% from FY2024) and net income of $46.9 million. Diluted EPS was $2.05.
- As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding STEPAN CO (SCL) shares worth $643.4 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.3B
- +7.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 29 funds
- $643.4M · −1 vs prior quarter
- Latest 8-K
- Oct 28, 2026
- Item 8.01 · Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- Legal risk from CERCLA Superfund cleanup liability at Maywood, NJ, with ongoing remediation costs and a 2024 consent decree involving USEPA and NJDEP
- Geopolitical risk from Brazil Supreme Court tax rulings and 2023 National Treasury rescission action impacting PIS/COFINS tax credits for 2012-2017 period
- Operational risk from USEPA Notice of Violation in March 2024 at Millsdale, IL facility alleging air regulation breaches with uncertain penalties
- Competitive risk from market exposure to chemical industry under Dow Jones Chemical Industry Index including major basic and specialty chemical producers
- Financial risk from stock repurchase authorization of up to $150 million with $125 million remaining as of December 2025 affecting capital allocation
Management Discussion & Analysis
- Net sales from Surfactants 71% of total in 2025, no total revenue or YoY change disclosed
- Sale of Philippines manufacturing assets completed in Q4 2025, transitioned to tolling agreement with Masurf, Inc
- No profitability, margin figures, or segment profit/loss data disclosed
- No management outlook, guidance, or risk commentary disclosed in provided text
AI summary of the SCL 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Q3 revenue $692.2M, up 17% YoY from $590.3M
- Operating margin 3.8% vs 3.7% YoY, operating income $26.0M vs $21.8M
- Best segment: Surfactants operating income $27.4M, up 75%; worst: Polymers Europe gross profit $4.7M, down 30%
- Cash $98.1M, down $34.6M from December 31; nine-month operating cash flow $54.6M vs $87.9M
- Restructuring charges $5.6M in Q3; full-year 2026 charges expected at $77.0M to $80.0M, with macroeconomic and construction-demand headwinds
Risk Factors
- No material changes to risk factors disclosed in the 2025 Form 10-K
- Carried-forward risks include regulatory, operational, market, liquidity, debt, currency, and concentration exposures
AI summary of the SCL 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Quarterly cash dividend declared at $0.405 per common share
- December 1, 2026 record date determines shareholder eligibility
Item EX-99.2: Item EX-99.2
- Quarterly dividend increased $0.010 to $0.405 per share, payable December 15, 2026
- Record date December 1, 2026, determining shareholder eligibility for payment
Item EX-99.1: Item EX-99.1
- Q3 reported EPS $0.78, up 66%, while adjusted EPS reached $0.94, up 96%, reflecting broad-based operating recovery
- Adjusted EBITDA $66.3M, up 18%, led by Surfactants growth of 27% and margin recovery
Item 2.02: Results of Operations and Financial Condition
- Stepan’s Q3 2026 financial results cover the quarter ended September 30, 2026
- Press release issued October 28, 2026, with detailed results in Exhibit 99.1
Item 1.01: Entry into a Material Definitive Agreement
- New $500.0M credit package: $350.0M revolving facility plus $150.0M delayed-draw term loan
- Five-year facilities mature September 25, 2031, replacing $450.0M of prior committed financing
Item 2.03: Creation of a Direct Financial Obligation
- Item 2.03 references Item 1.01 for details on a newly created direct financial obligation
- Investor impact depends on the referenced agreement’s amount, payment terms, maturity and purpose
Item 2.05: Costs Associated with Exit or Disposal Activities
- Board-approved reduction of approximately 100 global salaried roles in Q3 2026 under Project Catalyst
- Workforce reduction charges estimated at $4 million–$6 million, primarily severance and benefits
Item 8.01: Other Events
- Quarterly cash dividend declared at $0.395 per common share
- Payment scheduled for September 15, 2026, to shareholders of record September 1, 2026
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Jan Stern Reed resigned from the Board effective July 27, 2026, without disagreement with company operations or policies
- Reed’s exit removes the Human Capital and Compensation Committee chair and Audit, Compliance, and Governance Committee membership
Item EX-99.1: Item EX-99.1
- Q2 net sales $684.1M, up 15%, with volume up 3% and organic volume up 6%
- Adjusted EBITDA $74.4M, up 45%, led by Surfactants up 59% and Polymers up 22%
Item 2.02: Results of Operations and Financial Condition
- Stepan announced financial results for the quarter ended June 30, 2026
- Exhibit 99.1 contains the earnings press release and detailed operating results
Item EX-99.2: Item EX-99.2
- Quarterly dividend declared at $0.395 per share, payable September 15, 2026
- September 1, 2026 record date determines eligible shareholders
AI summaries of SCL 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for SCL
Don't miss the next SCL filing
- Alerts as it files. A push when SCL files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut SCL, by share count.
- Ask anything. An AI agent that reads every SCL filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Barry Andrea Jean | F | Nov 10, 2026 | 114 | $67.89 |
| Barry Andrea Jean | M | Nov 9, 2026 | 386 | - |
| Barry Andrea Jean | M | Nov 9, 2026 | 386 | $67.89 |
| STEPAN F QUINN JR | G | Nov 3, 2026 | 1,430 | - |
| Lisle Shawn G | M | Aug 26, 2026 | 1,154 | - |
| Lisle Shawn G | M | Aug 26, 2026 | 1,154 | $62.34 |
| Lisle Shawn G | F | Aug 26, 2026 | 339 | $62.34 |
| Velasquez Ruben Dario | M | Aug 10, 2026 | 1,358 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.2B | $2.3B |
| Gross Profit | - | $272.2M | $269.9M |
| Operating Income | - | $70.5M | $78.5M |
| Net Income | - | $50.4M | $46.9M |
| Gross Margin | - | 12.5% | 11.6% |
| Op. Margin | - | 3.2% | 3.4% |
| Net Margin | - | 2.3% | 2.0% |
| Balance Sheet | |||
| Total Assets | $2.4B | $2.3B | $2.4B |
| Equity | $1.2B | $1.2B | $1.2B |
| ROE | - | 4.3% | 3.8% |
| Per Share | |||
| EPS | - | $2.20 | $2.05 |
| Cash Flow | |||
| Operating CF | - | $162.1M | $147.9M |
| CapEx | - | $122.8M | $122.5M |
Source: XBRL data in STEPAN CO (SCL)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate SCL share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 29 | $643.4M |
| Q2 2026 | 30 | $585.9M |
| Q1 2026 | 30 | $503.5M |
| Q4 2025 | 28 | $507.9M |
| Q3 2025 | 28 | $530.3M |
| Q2 2025 | 28 | $594.9M |
| Q1 2025 | 25 | $434.9M |
| Q4 2024 | 20 | $464.5M |
- Dimensional Fund Advisors+67.0K (+6%)
- JPMorgan Chase & Co+19.6K (+26%)
- Ameriprise Financial+9.3K (+2%)
- T. Rowe Price Group+110 (+0%)
- HANCOCK WHITNEY CORP+97 (+1%)
- Millennium Management−59.4K (-63%)
- Two Sigma Investments−55.5K (-14%)
- Morgan Stanley−32.0K (-11%)
- BlackRock−30.6K (-1%)
- Goldman Sachs Group−26.7K (-13%)
- FMR LLC (Fidelity)−14.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 218 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
SCL filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 5, 2026 | - | - | - |
| 4 | Nov 5, 2026 | - | - | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 28, 2026 | - | Analysis | - |
| 8-K | Sep 28, 2026 | - | Analysis | - |
| 4 | Aug 28, 2026 | - | - | - |
| 4 | Aug 12, 2026 | - | - | - |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 29, 2026 | - | Analysis | - |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 4 | May 12, 2026 | - | - |
Related Consumer Staples companies
- CHD · Church & DwightSoap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- PG · Procter & GambleSoap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- ACI · Albertsons Companies IncRetail-Grocery Stores
- MO · AltriaCigarettes
- ANDE · Andersons, Inc.Wholesale-Farm Product Raw Materials
- BUD · Anheuser-Busch InBev SA/NVMalt Beverages
- ADM · Archer Daniels MidlandFats & Oils
- ARKO · ARKO Corp.Retail-Convenience Stores
SCL SEC filings: frequently asked questions
Which institutions hold SCL stock?
As of September 30, 2026, the largest STEPAN CO (SCL) holders among the 13F filers tracked by SignalX were BlackRock ($213.8 million), Vanguard Portfolio Management LLC ($86.2 million), Dimensional Fund Advisors ($74.4 million), Vanguard Capital Management LLC ($58.9 million), State Street Corp ($55.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was SCL's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), STEPAN CO (SCL) reported revenue of $2.3 billion (up 7.0% from FY2024) and net income of $46.9 million. Diluted EPS was $2.05. The figures come from the XBRL data in the 10-K.
What are the main risks in SCL's latest 10-K?
In the 10-K filed February 26, 2026, STEPAN CO (SCL) flagged: Legal risk from CERCLA Superfund cleanup liability at Maywood, NJ, with ongoing remediation costs and a 2024 consent decree involving USEPA and NJDEP. Geopolitical risk from Brazil Supreme Court tax rulings and 2023 National Treasury rescission action impacting PIS/COFINS tax credits for 2012-2017 period. (AI summary of the Risk Factors section.)
What did SCL report in its latest 8-K?
STEPAN CO (SCL) filed an 8-K on October 28, 2026 reporting Item 8.01 (Other Events) and Item 2.02 (Results of Operations and Financial Condition). Quarterly cash dividend declared at $0.405 per common share.
What are the latest SCL SEC filings?
STEPAN CO (SCL) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on October 28, 2026 and a Form 4 insider filing on November 10, 2026.
What is SCL's SEC CIK number?
STEPAN CO (SCL)'s SEC Central Index Key (CIK) is 94049. EDGAR lists every SCL filing under that number.
Ask anything about SCL
The research agent reads SCL's filings, financials, insider trades and 13F holders, then answers with sources.